Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

A comparative study on decision and documentation of refraining from resuscitation in two medical home care units in Sweden.

Sterpu B, Lindman P, Björkhem-Bergman L.

BMC Palliat Care. 2019 Oct 17;18(1):80. doi: 10.1186/s12904-019-0472-z.

2.

Death at home: predictive factors in a medical home care unit.

Rasch-Westin M, Helde-Frankling M, Björkhem-Bergman L.

BMJ Support Palliat Care. 2019 Sep 19. pii: bmjspcare-2019-001932. doi: 10.1136/bmjspcare-2019-001932. [Epub ahead of print]

PMID:
31537581
3.

Impact of vitamin D and vitamin D receptor TaqI polymorphism in primary human myoblasts.

Saini A, Björkhem-Bergman L, Boström J, Lilja M, Melin M, Olsson K, Ekström L, Bergman P, Altun M, Rullman E, Gustafsson T.

Endocr Connect. 2019 Jul 29;8(7):1070-1081. doi: 10.1530/EC-19-0194.

4.

Differences in discontinuation of statin treatment in women and men with advanced cancer disease.

Bergström H, Brånvall E, Helde-Frankling M, Björkhem-Bergman L.

Biol Sex Differ. 2018 Oct 20;9(1):47. doi: 10.1186/s13293-018-0207-5.

5.

Vitamin D binding protein is not affected by high-dose vitamin D supplementation: a post hoc analysis of a randomised, placebo-controlled study.

Björkhem-Bergman L, Torefalk E, Ekström L, Bergman P.

BMC Res Notes. 2018 Aug 29;11(1):619. doi: 10.1186/s13104-018-3725-7.

6.

Vitamin D supplementation to persistent carriers of MRSA-a randomized and placebo-controlled clinical trial.

Björkhem-Bergman L, Missailidis C, Karlsson-Valik J, Tammelin A, Ekström L, Bottai M, Hammar U, Lindh G, Bergman P.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1735-1744. doi: 10.1007/s10096-018-3306-7. Epub 2018 Jun 21.

7.

Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids.

Björkhem-Bergman L, Lehtihet M, Rane A, Ekström L.

BMC Res Notes. 2018 Jan 19;11(1):51. doi: 10.1186/s13104-018-3173-4.

8.

Tactile massage reduces rescue doses for pain and anxiety: an observational study.

Pedersen K, Björkhem-Bergman L.

BMJ Support Palliat Care. 2018 Mar;8(1):30-33. doi: 10.1136/bmjspcare-2017-001421. Epub 2017 Nov 4.

PMID:
29102921
9.

Vitamin D in Pain Management.

Helde-Frankling M, Björkhem-Bergman L.

Int J Mol Sci. 2017 Oct 18;18(10). pii: E2170. doi: 10.3390/ijms18102170. Review.

10.

Vitamin D supplementation to palliative cancer patients: protocol of a double-blind, randomised controlled trial 'Palliative-D'.

Helde-Frankling M, Bergqvist J, Klasson C, Nordström M, Höijer J, Bergman P, Björkhem-Bergman L.

BMJ Support Palliat Care. 2017 Dec;7(4):458-463. doi: 10.1136/bmjspcare-2017-001429. Epub 2017 Sep 13.

PMID:
28904010
11.

Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections-Results from a matched case-control study.

Helde-Frankling M, Höijer J, Bergqvist J, Björkhem-Bergman L.

PLoS One. 2017 Aug 31;12(8):e0184208. doi: 10.1371/journal.pone.0184208. eCollection 2017.

12.

The Pneumocell-study: Vaccination of IgG1- and IgG2-deficient patients with Prevnar13.

Zangenah S, Björkhem-Bergman L, Norlin AC, Hansen S, Lindqvist L, Henriques-Normark B, Bergman P.

Vaccine. 2017 May 9;35(20):2654-2660. doi: 10.1016/j.vaccine.2017.03.097. Epub 2017 Apr 11.

PMID:
28410816
13.

Genetic Expression Profile of Vitamin D Metabolizing Enzymes in the First Trimester.

Ekström L, Storbjörk L, Björkhem-Bergman L.

Horm Metab Res. 2016 Dec;48(12):834-839. Epub 2016 Nov 3.

PMID:
27813049
14.

Vitamin D3 Supplementation and Antibiotic Consumption - Results from a Prospective, Observational Study at an Immune-Deficiency Unit in Sweden.

Norlin AC, Hansen S, Wahren-Borgström E, Granert C, Björkhem-Bergman L, Bergman P.

PLoS One. 2016 Sep 22;11(9):e0163451. doi: 10.1371/journal.pone.0163451. eCollection 2016.

15.

Antibiotic Treatment in End-of-Life Cancer Patients-A Retrospective Observational Study at a Palliative Care Center in Sweden.

Helde-Frankling M, Bergqvist J, Bergman P, Björkhem-Bergman L.

Cancers (Basel). 2016 Sep 6;8(9). pii: E84. doi: 10.3390/cancers8090084.

16.

Vitamin D and patients with palliative cancer.

Björkhem-Bergman L, Bergman P.

BMJ Support Palliat Care. 2016 Sep;6(3):287-91. doi: 10.1136/bmjspcare-2015-000921. Epub 2016 Apr 15. Review.

PMID:
27084421
17.

miRNA-27b levels are associated with CYP3A activity in vitro and in vivo.

Ekström L, Skilving I, Ovesjö ML, Aklillu E, Nylén H, Rane A, Diczfalusy U, Björkhem-Bergman L.

Pharmacol Res Perspect. 2015 Oct 27;3(6):e00192. doi: 10.1002/prp2.192. eCollection 2015 Dec.

18.

Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations.

Björkhem-Bergman L, Nylén H, Eriksson M, Parini P, Diczfalusy U.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):499-502. doi: 10.1111/bcpt.12537. Epub 2016 Jan 14.

19.

Is There a Role for Statins in Palliative Care for Patients Suffering from Hepatocellular Carcinoma?

Björkhem-Bergman L.

J Palliat Care. 2015;31(3):172-6. Review. No abstract available.

PMID:
26514023
20.

Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin-Induced Myopathy.

Ovesjö ML, Skilving I, Bergman P, Rane A, Ekström L, Björkhem-Bergman L.

Basic Clin Pharmacol Toxicol. 2016 Mar;118(3):214-8. doi: 10.1111/bcpt.12482. Epub 2015 Oct 1.

21.

Vitamin D supplementation improves well-being in patients with frequent respiratory tract infections: a post hoc analysis of a randomized, placebo-controlled trial.

Bergman P, Norlin AC, Hansen S, Björkhem-Bergman L.

BMC Res Notes. 2015 Sep 29;8:498. doi: 10.1186/s13104-015-1504-2.

22.

Vitamin D supplementation to patients with frequent respiratory tract infections: a post hoc analysis of a randomized and placebo-controlled trial.

Bergman P, Norlin AC, Hansen S, Björkhem-Bergman L.

BMC Res Notes. 2015 Aug 30;8:391. doi: 10.1186/s13104-015-1378-3.

23.

Low vitamin D levels are associated with higher opioid dose in palliative cancer patients--results from an observational study in Sweden.

Bergman P, Sperneder S, Höijer J, Bergqvist J, Björkhem-Bergman L.

PLoS One. 2015 May 27;10(5):e0128223. doi: 10.1371/journal.pone.0128223. eCollection 2015.

24.

Possible mechanism for inhibition of morphine formation from 6-acetylmorphine after intake of street heroin.

Andersson M, Björkhem-Bergman L, Beck O.

Forensic Sci Int. 2015 Jul;252:150-6. doi: 10.1016/j.forsciint.2015.05.002. Epub 2015 May 12.

PMID:
26002801
25.

Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.

Betts S, Björkhem-Bergman L, Rane A, Ekström L.

Basic Clin Pharmacol Toxicol. 2015 Oct;117(4):261-6. doi: 10.1111/bcpt.12392. Epub 2015 Mar 9.

26.

Statin-induced Myopathy and Ubiquinone Levels in Serum - Results from a Prospective, Observational Study.

Skilving I, Acimovic J, Rane A, Ovesjö ML, Björkhem-Bergman L.

Basic Clin Pharmacol Toxicol. 2015 Aug;117(2):133-6. doi: 10.1111/bcpt.12375. Epub 2015 Jan 28.

27.

Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men.

Gårevik N, Rane A, Björkhem-Bergman L, Ekström L.

Subst Abuse Rehabil. 2014 Dec 10;5:121-7. doi: 10.2147/SAR.S71285. eCollection 2014.

28.

Detection of morphine-3-sulfate and morphine-6-sulfate in human urine and plasma, and formation in liver cytosol.

Andersson M, Björkhem-Bergman L, Ekström L, Bergqvist L, Lagercrantz H, Rane A, Beck O.

Pharmacol Res Perspect. 2014 Dec;2(6):e00071. doi: 10.1002/prp2.71. Epub 2014 Sep 1.

29.

Prenatal expression of thioredoxin reductase 1 (TRXR1) and microsomal glutathione transferase 1 (MGST1) in humans.

Björkhem-Bergman L, Johansson M, Morgenstern R, Rane A, Ekström L.

FEBS Open Bio. 2014 Oct 14;4:886-91. doi: 10.1016/j.fob.2014.10.005. eCollection 2014.

30.

Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.

Björkhem-Bergman L, Backheden M, Söderberg Löfdal K.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1101-6. doi: 10.1002/pds.3685. Epub 2014 Jul 29.

PMID:
25074765
31.

Ecological impact of MCB3837 on the normal human microbiota.

Rashid MU, Dalhoff A, Bäckström T, Björkhem-Bergman L, Panagiotidis G, Weintraub A, Nord CE.

Int J Antimicrob Agents. 2014 Aug;44(2):125-30. doi: 10.1016/j.ijantimicag.2014.03.016. Epub 2014 May 23.

PMID:
24931053
32.

Plasma levels of 25-hydroxyvitamin D3 and in vivo markers of cytochrome P450 3A activity in Swedes and Koreans: effects of a genetic polymorphism and oral contraceptives.

Nylén H, Björkhem-Bergman L, Ekström L, Roh HK, Bertilsson L, Eliasson E, Lindh JD, Diczfalusy U.

Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):366-71. doi: 10.1111/bcpt.12230. Epub 2014 Apr 11.

33.

Quinine compared to 4β-hydroxycholesterol and midazolam as markers for CYP3A induction by rifampicin.

Björkhem-Bergman L, Bäckström T, Nylén H, Rönquist-Nii Y, Bredberg E, Andersson TB, Bertilsson L, Diczfalusy U.

Drug Metab Pharmacokinet. 2014;29(4):352-5. Epub 2014 Feb 11.

34.

Is there a role for statins in fungal infections?

Bergman PW, Björkhem-Bergman L.

Expert Rev Anti Infect Ther. 2013 Dec;11(12):1391-400. doi: 10.1586/14787210.2014.856755. Review.

PMID:
24215244
35.

[Methylphenidate and cannabinoids may have a place in palliative care. Literature review and clinical experience provides evidence].

Björkhem-Bergman L, Wallin C.

Lakartidningen. 2013 Aug 7-20;110(32-33):1409-11. Swedish. No abstract available.

PMID:
23980382
36.

Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD.

PLoS One. 2013 Jun 19;8(6):e65835. doi: 10.1371/journal.pone.0065835. Print 2013. Review.

37.

Atorvastatin treatment induces uptake and efflux transporters in human liver.

Björkhem-Bergman L, Bergström H, Johansson M, Parini P, Eriksson M, Rane A, Ekström L.

Drug Metab Dispos. 2013 Sep;41(9):1610-5. doi: 10.1124/dmd.113.051698. Epub 2013 Jun 10.

PMID:
23751277
38.

Comparison of endogenous 4β-hydroxycholesterol with midazolam as markers for CYP3A4 induction by rifampicin.

Björkhem-Bergman L, Bäckström T, Nylén H, Rönquist-Nii Y, Bredberg E, Andersson TB, Bertilsson L, Diczfalusy U.

Drug Metab Dispos. 2013 Aug;41(8):1488-93. doi: 10.1124/dmd.113.052316. Epub 2013 May 14.

PMID:
23674608
39.

Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations.

Björkhem-Bergman L, Andersén-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, Malmström RE, Vogler S, Godman B, Gustafsson LL.

Eur J Clin Pharmacol. 2013 May;69 Suppl 1:73-8. doi: 10.1007/s00228-013-1497-5. Epub 2013 May 3.

PMID:
23640191
40.

Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study.

Björkhem-Bergman L, Nylén H, Norlin AC, Lindh JD, Ekström L, Eliasson E, Bergman P, Diczfalusy U.

Drug Metab Dispos. 2013 Apr;41(4):704-8. doi: 10.1124/dmd.113.051136. Epub 2013 Feb 5.

PMID:
23386704
41.

Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study.

Bergman P, Norlin AC, Hansen S, Rekha RS, Agerberth B, Björkhem-Bergman L, Ekström L, Lindh JD, Andersson J.

BMJ Open. 2012 Dec 13;2(6). pii: e001663. doi: 10.1136/bmjopen-2012-001663. Print 2012.

42.

Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.

Ekström L, Johansson M, Monostory K, Rundlöf AK, Arnér ES, Björkhem-Bergman L.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):90-4. doi: 10.1016/j.bbrc.2012.11.007. Epub 2012 Nov 12.

PMID:
23154180
43.

Influence of simvastatin on the thromboxane and prostacyclin pathways, in vitro and in vivo.

Skogastierna C, Björkhem-Bergman L, Bergman P, Eliasson E, Rane A, Ekström L.

J Cardiovasc Pharmacol. 2013 Jan;61(1):1-7. doi: 10.1097/FJC.0b013e3182734508.

PMID:
22987053
44.

Vitamin D and drug-metabolising enzymes.

Lindh JD, Björkhem-Bergman L, Eliasson E.

Photochem Photobiol Sci. 2012 Dec;11(12):1797-801. doi: 10.1039/c2pp25194a.

PMID:
22903070
45.

The anti-carcinogenic effect of statins in a rat model correlates with levels and synthesis of ubiquinone.

Acimovic J, Lövgren-Sandblom A, Eriksson LC, Björkhem-Bergman L.

Biochem Biophys Res Commun. 2012 Aug 24;425(2):348-52. doi: 10.1016/j.bbrc.2012.07.094. Epub 2012 Jul 26.

PMID:
22842579
46.

Review: Exploring anticarcinogenic agents in a rat hepatocarcinogenesis model--focus on selenium and statins.

Björkhem-Bergman L, Ekström L, Eriksson LC.

In Vivo. 2012 Jul-Aug;26(4):527-35. Review.

PMID:
22773564
47.

[Tranexamic acid after myocardial infarction. Referral to coagulation unit is recommended].

Björkhem Bergman L, Böttiger Y.

Lakartidningen. 2011 Nov 30-Dec 6;108(48):2512. Swedish. No abstract available.

PMID:
22462275
48.

Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.

Skogastierna C, Johansson M, Parini P, Eriksson M, Eriksson LC, Ekström L, Björkhem-Bergman L.

Biochem Biophys Res Commun. 2012 Jan 20;417(3):1046-51. doi: 10.1016/j.bbrc.2011.12.091. Epub 2011 Dec 26.

PMID:
22222370
49.

Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.

Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M.

Hepatology. 2012 Apr;55(4):1112-21. doi: 10.1002/hep.24808.

PMID:
22105228
50.

Studies on the antibacterial effects of statins--in vitro and in vivo.

Bergman P, Linde C, Pütsep K, Pohanka A, Normark S, Henriques-Normark B, Andersson J, Björkhem-Bergman L.

PLoS One. 2011;6(8):e24394. doi: 10.1371/journal.pone.0024394. Epub 2011 Aug 30.

Supplemental Content

Loading ...
Support Center